There are a lot of things about what's happened here right from the very beginning when Oda came aboard that have raised my eyebrows. Everything about Injex becoming Inojex in particular, as one disclaims the other.
I noticed before and I'm going to repeat myself because it goes to the point of how the transition was done. As an example, if you look at the studies on the website, they're taken from Injex and the name "Inolife" has merely been inserted in the text. You can make out a slight difference in the font. Also, in one picture which is not text, you'll still see the name "Injex".
The name "Medical Marketing Berlin" is also a dead giveaway that these studies were done for the German manufacturer, not the current owner of this ticker. Here's an old press release that shows this.
News 
Market Data 
Discover 
